Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ayush Praveen

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Cancer Research Communications|October 9, 2023
Targeting MALAT1 Augments Sensitivity to PARP Inhibition by Impairing Homologous Recombination in Prostate CancerAnjali Yadav, Tanay Biswas, Ayush Praveen, et al.
Advances in Experimental Medicine and Biology|May 3, 2026
Metabolomics: Fundamentals, Methods, Analysis, Limits, and RecommendationsAyush Praveen, Tripti Nair, Biplab Singha, et al.
Nature Communications|May 18, 2026
DKC1 promotes colorectal cancer progression and therapy resistance by dysregulating sphingolipid biosynthesisUmar K Khan, Ayush Goel, Shivansh Nigam, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Cancer Research Communications|October 9, 2023
Targeting MALAT1 Augments Sensitivity to PARP Inhibition by Impairing Homologous Recombination in Prostate CancerAnjali Yadav, Tanay Biswas, Ayush Praveen, et al.
Advances in Experimental Medicine and Biology|May 3, 2026
Metabolomics: Fundamentals, Methods, Analysis, Limits, and RecommendationsAyush Praveen, Tripti Nair, Biplab Singha, et al.
Nature Communications|May 18, 2026
DKC1 promotes colorectal cancer progression and therapy resistance by dysregulating sphingolipid biosynthesisUmar K Khan, Ayush Goel, Shivansh Nigam, et al.
Pageof 1